$3.42
+0.06
(+1.79%)▲
Insights on Docgo Inc
Revenue is up for the last 6 quarters, 104.31M → 199.24M (in $), with an average increase of 11.4% per quarter
Netprofit is up for the last 4 quarters, -3.46M → 7.57M (in $), with an average increase of 83.9% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 110.0%
2.05%
Downside
Day's Volatility :4.42%
Upside
2.43%
18.71%
Downside
52 Weeks Volatility :74.31%
Upside
68.39%
Period | Docgo Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 0.9% | -0.7% | 0.0% |
6 Months | -44.37% | 6.6% | 0.0% |
1 Year | -57.14% | 3.7% | -1.5% |
3 Years | -55.2% | 14.0% | -21.8% |
Market Capitalization | 339.6M |
Book Value | $2.89 |
Earnings Per Share (EPS) | 0.06 |
PE Ratio | 54.33 |
Wall Street Target Price | 9.89 |
Profit Margin | 1.1% |
Operating Margin TTM | 5.86% |
Return On Assets TTM | 2.17% |
Return On Equity TTM | 3.44% |
Revenue TTM | 624.3M |
Revenue Per Share TTM | 6.03 |
Quarterly Revenue Growth YOY | 83.2% |
Gross Profit TTM | 154.7M |
EBITDA | 31.8M |
Diluted Eps TTM | 0.06 |
Quarterly Earnings Growth YOY | -0.16 |
EPS Estimate Current Year | 0.32 |
EPS Estimate Next Year | 0.4 |
EPS Estimate Current Quarter | 0.1 |
EPS Estimate Next Quarter | 0.09 |
What analysts predicted
Upside of 189.18%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 48.3M | - |
Net Income | -21.2M | - |
Net Profit Margin | -43.97% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 94.1M | ↑ 94.81% |
Net Income | -14.8M | ↓ 30.32% |
Net Profit Margin | -15.73% | ↑ 28.24% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 318.7M | ↑ 238.74% |
Net Income | 23.7M | ↓ 260.44% |
Net Profit Margin | 7.45% | ↑ 23.18% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 440.5M | ↑ 38.21% |
Net Income | 34.6M | ↑ 45.66% |
Net Profit Margin | 7.85% | ↑ 0.4% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 624.3M | ↑ 41.72% |
Net Income | 6.9M | ↓ 80.17% |
Net Profit Margin | 1.1% | ↓ 6.75% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 104.3M | ↓ 4.75% |
Net Income | 2.5M | ↓ 80.63% |
Net Profit Margin | 2.36% | ↓ 9.27% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 108.8M | ↑ 4.28% |
Net Income | 8.1M | ↑ 226.97% |
Net Profit Margin | 7.41% | ↑ 5.05% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 113.0M | ↑ 3.88% |
Net Income | -3.5M | ↓ 142.97% |
Net Profit Margin | -3.07% | ↓ 10.48% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 125.5M | ↑ 11.05% |
Net Income | -2.0M | ↓ 41.97% |
Net Profit Margin | -1.6% | ↑ 1.47% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 186.6M | ↑ 48.66% |
Net Income | 4.8M | ↓ 336.91% |
Net Profit Margin | 2.55% | ↑ 4.15% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 199.2M | ↑ 6.8% |
Net Income | 7.6M | ↑ 58.88% |
Net Profit Margin | 3.8% | ↑ 1.25% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 101.0M | - |
Total Liabilities | 21.6M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 100.2M | ↓ 0.78% |
Total Liabilities | 33.2M | ↑ 53.81% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 309.6M | ↑ 209.07% |
Total Liabilities | 82.5M | ↑ 148.44% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 393.3M | ↑ 27.03% |
Total Liabilities | 114.4M | ↑ 38.53% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 490.5M | ↑ 24.71% |
Total Liabilities | 185.3M | ↑ 62.03% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 355.9M | ↑ 7.25% |
Total Liabilities | 85.1M | ↑ 9.84% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 393.3M | ↑ 10.5% |
Total Liabilities | 114.4M | ↑ 34.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 407.5M | ↑ 3.63% |
Total Liabilities | 123.6M | ↑ 8.11% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 390.3M | ↓ 4.23% |
Total Liabilities | 106.4M | ↓ 13.91% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 419.8M | ↑ 7.56% |
Total Liabilities | 128.2M | ↑ 20.49% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 490.5T | ↑ 1.168342222E8% |
Total Liabilities | 185.3T | ↑ 1.4448910352E8% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -14.2M | - |
Investing Cash Flow | -3.0M | - |
Financing Cash Flow | 56.3M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -10.7M | ↓ 25.0% |
Investing Cash Flow | -6.0M | ↑ 103.28% |
Financing Cash Flow | -812.1K | ↓ 101.44% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.9M | ↓ 81.72% |
Investing Cash Flow | -8.6M | ↑ 42.2% |
Financing Cash Flow | 155.2M | ↓ 19211.91% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 28.9M | ↓ 1582.47% |
Investing Cash Flow | -38.4M | ↑ 347.63% |
Financing Cash Flow | -6.2M | ↓ 103.98% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.4M | ↓ 37.76% |
Investing Cash Flow | -35.8M | ↑ 4264.67% |
Financing Cash Flow | -436.4K | ↓ 68.25% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -8.7M | ↓ 217.75% |
Investing Cash Flow | -654.0K | ↓ 98.18% |
Financing Cash Flow | -6.9M | ↑ 1473.19% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -23.1M | ↑ 164.58% |
Investing Cash Flow | -1.7M | ↑ 158.33% |
Financing Cash Flow | -12.0M | ↑ 74.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 10.7M | ↓ 146.25% |
Investing Cash Flow | -23.7M | ↑ 1304.44% |
Financing Cash Flow | 8.8M | ↓ 173.3% |
Sell
Neutral
Buy
Docgo Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Docgo Inc | -8.7% | -44.37% | -57.14% | -55.2% | -55.2% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Docgo Inc | 54.33 | 54.33 | NA | 0.32 | 0.03 | 0.02 | NA | 2.89 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Docgo Inc | Buy | $339.6M | -55.2% | 54.33 | 1.1% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
BlackRock Inc
Hood River Capital Management LLC
Vanguard Group Inc
Deerfield Management Co
WCM Investment Management
Emerald Advisers, LLC
DocGo is a leading provider of mobile medical services and transportation in 26 US States and in the United Kingdom.
Organization | Docgo Inc |
Employees | 2915 |
CEO | Mr. Lee Bienstock |
Industry | Transportation |